Assessing the efficacy of clinical drugs targeting SARS-CoV-2 main protease

PHYSorg
Nov 6, 2024, 2:56 pm26 pts
Over the last few years, the SARS-CoV-2 virus, responsible for COVID-19, has undergone significant changes, evolving from the original wild-type strains to the highly transmissible omicron variant.

Read Article Share
Share Article
- email
- twitter
- facebook
- pocket
- reddit
- tumblr
- linkedin
- pinterest

Trending Today on EcoTopical

Cells have more mini 'organs' than once thought—these rogue organelles challenge biology's fundamentals 99

New modeling of complex biological systems could offer insights into genomic data and other huge datasets 98

Is the delay of Europe’s deforestation regulation a cause for regret, or an opportunity? (commentary) 94

Shared Micromobility Trips in North America Offset Approximately 81 Million Pounds of Carbon Dioxide Emissions Last Year 86

Another season of highs and lows as 2024 Australian humpback migration ends 82

Canada Announces Plan to Slash Oil and Gas Emissions 35% by 2030 77

EU Accused of Inviting Fossil Fuel Executives to COP28 Under False Pretences 76

Novel AI framework incorporates experimental data and text-based narratives to accelerate search for new proteins 75

About EcoTopical

Welcome to EcoTopical Your daily eco-friendly green news aggregator.

Leaf through planet Earths environmental headlines in one convenient place. Read, share and discover the latest on ecology, science and green living from the web's most popular sites.